Indoco Remedies Limited (INDOCO.BO)
INR 235.05
(0.45%)
INR 235.05
(0.45%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.51 Billion INR | 121.86% |
| 2022 | 1.58 Billion INR | 48.38% |
| 2021 | 1.06 Billion INR | 2.79% |
| 2020 | 1.03 Billion INR | 1.49% |
| 2019 | 1.02 Billion INR | -20.39% |
| 2018 | 1.28 Billion INR | 4.37% |
| 2017 | 1.23 Billion INR | -6.83% |
| 2016 | 1.32 Billion INR | 249.24% |
| 2015 | 378.85 Million INR | 196.4% |
| 2014 | 127.81 Million INR | -7.3% |
| 2013 | 137.88 Million INR | -49.65% |
| 2012 | 273.85 Million INR | -40.78% |
| 2011 | 462.41 Million INR | -14.44% |
| 2010 | 540.45 Million INR | -18.16% |
| 2009 | 660.39 Million INR | 18.48% |
| 2008 | 557.37 Million INR | 0.0% |
| 2006 | 355.52 Million INR | 6.89% |
| 2005 | 332.59 Million INR | -33.15% |
| 2004 | 497.55 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 4.32 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 3.51 Billion INR | 121.86% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 2.5 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 3.51 Billion INR | 0.0% |
| 2022 FY | 1.58 Billion INR | 48.38% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 1.11 Billion INR | 0.0% |
| 2022 Q4 | 1.58 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 1.06 Billion INR | 2.79% |
| 2021 Q4 | 1.06 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 1.06 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 1.03 Billion INR | 0.0% |
| 2020 FY | 1.03 Billion INR | 1.49% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 903.7 Million INR | 0.0% |
| 2019 Q2 | 1.04 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 1.02 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 1.02 Billion INR | -20.39% |
| 2018 FY | 1.28 Billion INR | 4.37% |
| 2018 Q4 | 1.28 Billion INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 1.23 Billion INR | -6.83% |
| 2016 FY | 1.32 Billion INR | 249.24% |
| 2015 FY | 378.85 Million INR | 196.4% |
| 2014 FY | 127.81 Million INR | -7.3% |
| 2013 FY | 137.88 Million INR | -49.65% |
| 2012 Q4 | 273.85 Million INR | 0.0% |
| 2012 FY | 273.85 Million INR | -40.78% |
| 2011 FY | 462.41 Million INR | -14.44% |
| 2010 FY | 540.45 Million INR | -18.16% |
| 2009 FY | 660.39 Million INR | 18.48% |
| 2008 FY | 557.37 Million INR | 0.0% |
| 2006 FY | 355.52 Million INR | 6.89% |
| 2005 FY | 332.59 Million INR | -33.15% |
| 2004 FY | 497.55 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -459.367% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 83.525% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -2282.833% |
| Granules India Limited | 689.71 Million INR | -409.968% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 235.2 Million INR | -1395.451% |
| Alkem Laboratories Limited | 400 Million INR | -779.325% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -98561.992% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -12535.795% |
| Bajaj HealthCare Limited | 650.34 Million INR | -440.836% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -888.222% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 41.28% |
| Eris Lifesciences Limited | 6.54 Billion INR | 46.26% |
| FDC Limited | 2.46 Million INR | -142531.792% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -131.873% |
| Gufic Biosciences Limited | 1.53 Billion INR | -128.451% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -3050.968% |
| Ipca Laboratories Limited | 5.8 Billion INR | 39.4% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -4554.36% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -91.678% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | 59.12% |
| Lupin Limited | 1.55 Billion INR | -126.513% |
| Mankind Pharma Limited | 248.67 Million INR | -1314.405% |
| Medicamen Biotech Limited | 12.55 Million INR | -27915.133% |
| Medico Remedies Limited | 8.67 Million INR | -40459.271% |
| Megasoft Limited | 1.35 Billion INR | -159.184% |
| NATCO Pharma Limited | 53 Million INR | -6536.415% |
| Piramal Pharma Limited | 24.83 Billion INR | 85.839% |
| RPG Life Sciences Limited | -30.3 Million INR | 11708.251% |
| Sigachi Industries Limited | 265.79 Million INR | -1223.298% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -26345.865% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -1556.322% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 288639.787% |
| Unichem Laboratories Limited | 382.22 Million INR | -820.227% |
| Wanbury Limited | 820 Million INR | -328.939% |
| Windlas Biotech Limited | 20.18 Million INR | -17329.633% |
| ZIM Laboratories Limited | 356 Million INR | -887.989% |
| Zydus Lifesciences Limited | 251 Million INR | -1301.315% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -3199.531% |
| Divi's Laboratories Limited | 20 Million INR | -17486.5% |
| Hester Biosciences Limited | 1.81 Billion INR | -93.5% |
| Procter & Gamble Health Limited | 68.8 Million INR | -5012.355% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -25081.128% |
| Bal Pharma Limited | 363.82 Million INR | -866.759% |
| Strides Pharma Science Limited | 6.71 Billion INR | 47.62% |
| Venus Remedies Limited | 386.8 Million INR | -809.333% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -879225.0% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -150.683% |
| Shilpa Medicare Limited | 5.6 Billion INR | 37.209% |
| Aarti Drugs Limited | 2.75 Billion INR | -27.749% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 65.158% |
| Valiant Laboratories Limited | 746.63 Million INR | -371.09% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -1387.86% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | -232.354% |
| Themis Medicare Limited | 267.74 Million INR | -1213.7% |
| Hikal Limited | 4.22 Billion INR | 16.819% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 78.072% |
| Sequent Scientific Limited | 1.42 Billion INR | -146.449% |
| Novartis India Limited | 50.7 Million INR | -6837.475% |
| Wockhardt Limited | 8.91 Billion INR | 60.524% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 88.894% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 449.2 Million INR | -683.004% |
| Morepen Laboratories Limited | 33.64 Million INR | -10355.707% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -2533.873% |